Ask Edgar App

Ticker: $VIVK Form Type: 8-K Summary: Vivakor, Inc. entered into a consulting agreement with its former Chief Operating Officer, Les Patterson, to provide logistical services in exchange for $20,000 in shares per month. Additionally, the company fully satisfied its obligations under its convertible promissory notes with J.J. Astor & Co., with J.J. Astor converting $844,622 of the amount due under its Fourth Note into 4,351,341 shares of common stock. Link: app.askedgar.io/filing?ticke…

Ticker: $VEEA Form Type: DEF 14A Summary: This SEC filing is a Definitive Proxy Statement (Form DEF 14A) for Veea Inc. for its upcoming virtual 2026 Annual Meeting of Stockholders scheduled for December 28, 2026. The proxy materials outline three key proposals for stockholder vote: electing Alan Black as a Class II director, approving an amendment to the 2024 Equity Incentive Plan to increase the reserved common stock from 553,022 to 750,000 shares, and ratifying the appointment of PKF O’Connor Davies, LLP as the independent registered public accounting firm for 2026. Link: app.askedgar.io/filing?ticke…

Ticker: $PEPG Form Type: 424B5 Summary: PepGen Inc. is offering $125,000,000 of its common stock and, in lieu of common stock to certain electing investors, pre-funded warrants to purchase shares of common stock. The offering is being managed by a syndicate of underwriters including Leerink Partners, Stifel, and Guggenheim Securities, who have been granted a 30-day option to purchase additional shares of common stock. The net proceeds from this offering will be used to fund ongoing clinical development of the company's product candidates, as well as for working capital and other general corporate purposes. Link: app.askedgar.io/filing?ticke…

Ticker: $KULR Form Type: 8-K Summary: On October 23, 2026, KULR Technology Group, Inc. filed a verified petition in the Delaware Court of Chancery seeking the validation of certain corporate acts, its outstanding common stock, and its Series A Voting Preferred Stock. The legal action under Section 205 of the Delaware General Corporation Law aims to resolve uncertainties regarding the company's capitalization and board composition. Link: app.askedgar.io/filing?ticke…

Ticker: $RUBI Form Type: F-1MEF Summary: Rubico Inc. filed this Form F-1MEF registration statement to increase the proposed maximum number of shares of common stock being offered by 48,000,000 following a reverse stock split that took effect on October 30, 2026. The additional shares are being registered pursuant to Rule 462(b) of the Securities Act to supplement previous registration statements for the same offering. Because the added securities do not change the maximum aggregate offering price set in the earlier filings, no additional filing fee is required. Link: app.askedgar.io/filing?ticke…

Ticker: $HUMA Form Type: 10-Q Summary: Humacyte, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, reporting product revenue of $1.0 million and a net loss of $15.5 million. As of September 30, 2026, the company had $64.5 million in cash and cash equivalents, which raises substantial doubt about its ability to continue as a going concern without additional capital. Operating expenses for the quarter totaled $24.5 million, consisting of $1.4 million in cost of goods sold, $14.1 million in research and development, and $9.0 million in general and administrative expenses. Link: app.askedgar.io/filing?ticke…

Ticker: $ZIP Form Type: 144 Summary: Boris Shimanovsky, an officer of ZipRecruiter Inc., filed a Form 144 to propose the sale of 67,937 shares of common stock with an approximate aggregate market value of $291,449.73 through Morgan Stanley Smith Barney LLC. The securities to be sold were originally acquired through the vesting of restricted stock units and an employee stock purchase plan between June 2021 and December 2022. The planned sale is associated with a Rule 10b5-1 trading plan adopted by the reporting person. Link: app.askedgar.io/filing?ticke…

Ticker: $AAON Form Type: 8-K Summary: AAON, Inc. announced that its Board of Directors has declared a regular quarterly cash dividend of $0.10 per share. The dividend will be paid on December 17, 2026, to stockholders who own shares as of the close of business on November 25, 2026. Link: app.askedgar.io/filing?ticke…

Ticker: $CODX Form Type: 10-Q Summary: For the quarterly period ended September 30, 2026, Co-Diagnostics, Inc. reported total revenue of $282,881 and a net loss of $6,306,408, compared to revenue of $145,380 and a net loss of $5,886,823 for the same period in 2025. As of September 30, 2026, the company held cash and cash equivalents of $714,803, total current assets of $1,938,098, and total current liabilities of $2,511,820, prompting management to conclude that substantial doubt exists regarding the company's ability to continue as a going concern. Link: app.askedgar.io/filing?ticke…

Ticker: $WCT Form Type: 6-K Summary: Wellchange Holdings Company Limited filed a Form 6-K to furnish its Management’s Discussion and Analysis of Financial Condition and Results of Operations alongside its Unaudited Interim Consolidated Financial Statements for the six months ended June 30, 2026 and 2025. These documents are included as exhibits 99.1 and 99.2 of the report. Link: app.askedgar.io/filing?ticke…

Ticker: $GMHS Form Type: 6-K Summary: Gamehaus Holdings Inc. announced updates regarding its acquisition of a 56.0% equity interest in Techforge Co., Ltd, noting that the share purchase portion was completed on November 9, 2026. Because Techforge is considered a significant business, this filing includes its audited financial statements for the fiscal years ended June 30, 2025 and 2026, along with unaudited pro forma condensed combined financial information for Gamehaus. Link: app.askedgar.io/filing?ticke…

Ticker: $CKX Form Type: 4 Summary: Reporting owner Lee W. Boyer, Secretary of CKX Lands, Inc., decreased their position by selling 962 shares of Common Stock at a price of $22.05 per share on November 9, 2026. Following this transaction, they directly own 2,000 shares of the company. Link: app.askedgar.io/filing?ticke…

Ticker: $MI Form Type: 6-K Summary: NFT Limited issued a statement regarding unusual trading activity in its securities on November 10, 2026. The company stated that, after inquiring with management, it is not aware of any undisclosed information or business developments that would explain the trading activity. Furthermore, management cannot determine the reasons for the unusual investor trading and will continue to disclose material developments as required. Link: app.askedgar.io/filing?ticke…

Ticker: $AMIX Form Type: 10-Q Summary: Autonomix Medical, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, reporting no product revenues and a net loss of $3.1 million for the quarter. As of September 30, 2026, the company had $7.7 million in cash and cash equivalents, which management estimates will fund operations into but not beyond the second calendar quarter of 2027. During the quarter, the company completed a 1-for-21 reverse stock split and raised gross proceeds of approximately $7.5 million through warrant inducements and exercises. Link: app.askedgar.io/filing?ticke…

Ticker: $SMX Form Type: 6-K Summary: SMX (Security Matters) Public Limited Company submitted a Form 6-K report to the SEC on November 10, 2026, including a press release filed as Exhibit 99.1. The report was signed by Chief Executive Officer Haggai Alon. Link: app.askedgar.io/filing?ticke…

Ticker: $MNDO Form Type: 6-K Summary: MIND C.T.I. Ltd. entered into a Merger Agreement on November 10, 2026, to be acquired by Enghouse Holdings (UK) Limited, a wholly-owned subsidiary of Enghouse Systems Limited, in an all-cash transaction. Under the agreement, a newly formed subsidiary of the buyer will merge with and into MIND C.T.I., leaving MIND C.T.I. as the surviving corporation and a wholly-owned subsidiary of the buyer. Link: app.askedgar.io/filing?ticke…

Ticker: $CODX Form Type: 8-K Summary: Co-Diagnostics, Inc. filed a Form 8-K to announce its financial results for the quarter ended September 30, 2026. The company issued a press release detailing these results, which includes information on a non-GAAP financial measure and is attached as an exhibit to the filing. Link: app.askedgar.io/filing?ticke…

Ticker: $PEPG Form Type: 8-K Summary: On November 10, 2026, PepGen Inc. issued a press release announcing its financial results for the quarter ended September 30, 2026, along with recent business updates. Additionally, the company announced positive Phase 2 FREEDOM2-DM1 10mg/kg clinical trial results demonstrating high splicing correction and functional improvements. PepGen also furnished a related investor presentation to be used in upcoming meetings. Link: app.askedgar.io/filing?ticke…

Ticker: $CKX Form Type: 8-K Summary: CKX Lands, Inc. entered into an Investment Agreement with Jacobs Private Equity II, LLC (JPE) and other investors for a $1,000,000,000 cash equity investment in the company. Following the transaction, JPE will become the controlling stockholder, and Brad Jacobs will take over as Chairman and CEO of the company. As part of the reorganization, existing stockholders will receive an aggregate cash dividend of $20,800,660, and the company will issue convertible preferred stock and warrants to the investors. Link: app.askedgar.io/filing?ticke…

Ticker: $CKX Form Type: DEFA14A Summary: CKX Lands, Inc. entered into an Investment Agreement with Jacobs Private Equity II, LLC (JPE) and other investors for a $1,000,000,000 cash equity investment in the company. Following the transaction, JPE will become the controlling stockholder, and Brad Jacobs will take over as Chairman and CEO of the company. As part of the reorganization, the company will convert to a Delaware corporation, enact a 4.1744380:1 reverse stock split, issue convertible preferred stock and warrants to the investors, and pay an aggregate cash dividend of $20,800,660 to existing stockholders. Link: app.askedgar.io/filing?ticke…